IntelGenx Corp. (IGXT.OB) and RedHill Biopharma Ltd. Announce Agreement for Anti-Migraine Film Product
IntelGenx Corp. has focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems to separate themselves from the competition in the medical sector. Today, IntelGenx took a major step forward with the announcement that they have entered a definitive agreement with RedHill Biopharma for an Anti-Migraine film product. The product is intended for the rapid relief of migraines and will be the first oral thin film product based upon IntelGenx's proprietary VersaFilm technology. The terms of this co-development and commercialization agreement will have Red Hill obtaining certain exclusive rights to market and sell the…